303 results on '"Yamada, Tesshi"'
Search Results
2. Predicting the prognosis of lower rectal cancer using preoperative magnetic resonance imaging with artificial intelligence
3. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
4. Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence
5. Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846
6. Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma
7. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics
8. Actinin-4, a Novel Actin-Bundling Protein Associated with Cell Motility and Cancer Invasion
9. Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients
10. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer
11. Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine
12. Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing
13. Alternative Mammalian Target of Rapamycin (mTOR) Signal Activation in Sorafenib-resistant Hepatocellular Carcinoma Cells Revealed by Array-based Pathway Profiling
14. A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumab
15. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis
16. WNT Pathway Gene Mutations Are Associated With the Presence of Dysplasia in Colorectal Sessile Serrated Adenoma/Polyps
17. CHFR Protein Regulates Mitotic Checkpoint by Targeting PARP-1 Protein for Ubiquitination and Degradation
18. β-Catenin Inhibits Promyelocytic Leukemia Protein Tumor Suppressor Function in Colorectal Cancer Cells
19. Developments for a growing Japanese patient population: Facilitating new technologies for future health care
20. CXCL17 and ICAM2 Are Associated With a Potential Anti-Tumor Immune Response in Early Intraepithelial Stages of Human Pancreatic Carcinogenesis
21. Traf2- and Nck-interacting Kinase Is Essential for Canonical Wnt Signaling in Xenopus Axis Formation
22. Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment
23. Prolyl 4-Hydroxylation of α-Fibrinogen: A NOVEL PROTEIN MODIFICATION REVEALED BY PLASMA PROTEOMICS
24. Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
25. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance
26. Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation
27. Blood Group A Cross-Reacting Epitope Defined by Monoclonal Antibodies NCC-LU-35 and -81 Expressed in Cancer of Blood Group O or B Individuals: Its Identification as Tn Antigen
28. Structural Insight into TNIK Inhibition.
29. Regulation of Wnt Signaling by the Nuclear Pore Complex
30. Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type
31. Functional Interaction of DNA Topoisomerase IIα With the β-Catenin and T-Cell Factor-4 Complex
32. Mass Spectrometry Analysis of the Native Protein Complex Containing Actinin-4 in Prostate Cancer Cells
33. Involvement of Splicing Factor-1 in β-Catenin/T-Cell Factor-4-Mediated Gene Transactivation and Pre-mRNA Splicing
34. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): Up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer
35. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic β-catenin protein
36. Alternative splice variant of actinin-4 in small cell lung cancer
37. Soluble interleukin-6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy
38. Proteomic Approaches to the Discovery of Cancer Biomarkers for Early Detection and Personalized Medicine
39. Label-free Quantitative Proteomics Using Large Peptide Data Sets Generated by Nanoflow Liquid Chromatography and Mass Spectrometry
40. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line
41. ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas
42. Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney
43. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray
44. Functional genome screen for therapeutic targets of osteosarcoma
45. Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma
46. Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry
47. Two-dimensional electrophoresis database of fluorescence-labeled proteins of colon cancer cells
48. IDENTIFICATION OF 2 SERUM BIOMARKERS OF RENAL CELL CARCINOMA BY SURFACE ENHANCED LASER DESORPTION/IONIZATION MASS SPECTROMETRY
49. β-Catenin Interacts With the FUS Proto-oncogene Product and Regulates Pre-mRNA Splicing
50. Poly(ADP-Ribose) Polymerase-1 Is a Component of the Oncogenic T-Cell Factor-4/β-Catenin Complex
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.